v3.26.1
Note 10 - Segments - Schedule of Segment Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Product revenue $ 226 $ 45
Cost of sales 206 33
Research and development 563 601
Sales and marketing 18 10
General and administrative [1] 1,045 1,071
Total operating expenses 1,832 1,715
Other segment items [2] (5) (11)
Net loss (1,601) (1,659)
Other segment items [2] 5 11
Regenerative Biotech [Member]    
Product revenue 0 0
Cost of sales 0 0
Research and development 563 601
Sales and marketing 2 8
General and administrative [1] 1,044 1,071
Total operating expenses 1,609 1,680
Other segment items [2] (5) (11)
Net loss (1,604) (1,669)
Other segment items [2] 5 11
Consumer Health Products [Member]    
Product revenue 226 45
Cost of sales 206 33
Research and development 0 0
Sales and marketing 16 2
General and administrative [1] 1 0
Total operating expenses 223 35
Other segment items [2] (0) (0)
Net loss 3 10
Other segment items [2] $ 0 $ 0
[1] Certain general and administrative costs (including executive compensation, corporate legal fees, audit fees, investor relations, and insurance) are shared across both segments. For internal reporting purposes, such costs are allocated to each segment based on an estimate of the proportion of management time and corporate resources utilized by each segment. Costs directly attributable to a segment are charged directly to that segment. For the three months ended March 31, 2026 and 2025, the Regenerative Biotech segment bore substantially all general and administrative expense, as the Consumer Health Products segment incurred minimal shared corporate overhead.
[2] “Other segment items” for the Regenerative Biotech segment consists primarily of net interest income earned on money market balances and other miscellaneous income, partially offset by interest expense on insurance premium financing. For the Consumer Health Products segment, other segment items consist of foreign currency transaction effects and other minor income items. The other segment items line represents the arithmetic difference between segment revenues, less the significant expense categories disclosed above, and the reported segment net loss, in accordance with ASC 280-10-50-26B.